BeiGene vs TippingPoint Biosciences
BeiGene vs TippingPoint Biosciences, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 65/100 and TippingPoint Biosciences on 59/100.
Where each one leads
BeiGene
- our overall score: 65/100 against 59/100
- agent readiness: 50/100 against 30/100
- funding raised: $358M against $14.5M
TippingPoint Biosciences
- domain rating: 90/100 against 69/100
At a glance
| Measure | BeiGene | TippingPoint Biosciences |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Antibody Therapeutics, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2010 | 2021 |
| Headquarters | Cambridge, United States | Cambridge, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | BeiGene | TippingPoint Biosciences |
|---|---|---|
| Employees | Not published | 7 |
| Open roles | 99 | Not published |
| Total funding | $358M | $14.5M |
| Latest round | Secondary Offering | Seed |
| Valuation | $15B | $1.1B |
| LinkedIn followers | Not published | 1,122 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | TippingPoint Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 65/100 | 59/100 |
| Traction | 40/100 | 45/100 |
| Team | 40/100 | 60/100 |
| Search visibility | 17/100 | 38/100 |
| Quality | 88/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 69/100 | 90/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | TippingPoint Biosciences |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
BeiGene vs TippingPoint Biosciences: common questions
Which is better, BeiGene or TippingPoint Biosciences?
On our 0-100 score BeiGene rates higher (65/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BeiGene and TippingPoint Biosciences compare on the numbers?
BeiGene leads on our overall score (65/100 against 59/100), agent readiness (50/100 against 30/100), funding raised ($358M against $14.5M). TippingPoint Biosciences leads on domain rating (90/100 against 69/100).
Read the full BeiGene review and pricing or the TippingPoint Biosciences review and pricing. You can also browse other BeiGene alternatives we track.